About

Neowe R&D is a pioneering MedTech company dedicated to modernizing patient care through innovative solutions. Our flagship product, Ouipan, is a smart, connected bedpan system designed to address long-standing challenges in clinical settings. The traditional bedpan has remained virtually unchanged for nearly 200 years, leading to poor patient experiences, increased infection risks, and significant inefficiencies for healthcare providers. Ouipan represents a critical innovation in bedside care, integrating technology, real time data monitoring, and hygienic advancements to enhance patient dignity, improve clinical workflows, and reduce healthcare costs. With strong Intellectual Protection we ensure our competitive edge.

Despite advancements in medical technology, bedpan-related issues remain a persistent problem in hospital and long term care facilities. Manual handling of bedpans leads to cross-contamination, pressure injuries, infections, costing the healthcare system billions in preventable complications. Moreover, the process is labor-intensive, increasing the burden on nurses and caregivers while contributing to burnout and inefficiencies in patient management.

Ouipan is designed to streamline patient care, enhance hygiene, and integrate digital monitoring into hospital and long term care workflows. Key features include:

1. Real-time patient monitoring that provides data and other vital indicators.

2. Automated waste disposal and self cleaning functionality to minimize cross contamination and infection risks.

3. Patient comfort enhancements, including ergonomic design and temperature controlled surfaces to reduce discomfort and pressure injuries.

4. Nurse and caregiver support, reducing time spent on manual bedpan handling, allowing staff to focus on higher value patient care tasks.

5. Integration with electronic health records (EHRs) to support clinical decision making.

The market for smart medical devices is rapidly expanding, with digital health solutions becoming an industry standard. Neowe is strategically positioned to capitalize on major revenue opportunities with new reimbursement models introduced by CMS.The bedpan market is valued at $850 million while the broader MedTech industry stands at $172.2 billion, presenting substantial expansion opportunities.

As we advance, Neowe R&D is actively seeking strategic partnerships with healthcare providers, clinical study collaborations to validate Ouipan"s impact on hospital efficiency, infection reduction and patient outcomes and investment and funding opportunities to accelerate regulatory approvals, market entry, and commercial scale manufacturing.

Neowe R&D is on a mission to revolutionize bedside patient care with smart technology. Ouipan is not just an upgrade, it's an essential evolution in modern healthcare. By transforming a neglected yet critical aspect of patient management, we aim to improve health outcomes, reduce costs, and enhance dignity and comfort of patients worldwide.